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The complement system In renal homograft 
. . 
recIpIents 
Takeo Yokoyama, M.D., Motomichi Torisu, M.D., Arie L. Durst, M.D., 
Gerhard Schroter, M.D., Carl G. Groth, M.D., and Thomas E. Starzl, M.D., Ph.D., 
Denver, Colo. 
The whole serum complement and its components were studied in 24 recipients of 
27 renal homografts. In 12 of 13 instances in which homograft rejection was diagnosed, 
it was accompanied by significant declines in CHSO, IASO, C4, and C3 levels, and to 
a lesser degree in C1 and C2 levels. Fourteen patients had normal graft function during 
the postoperative course of study, and in 13 of the 14 the complement levels were 
within the normal range throughout. In two recipients with systemic lupus 
erythematosus, very low initial complement levels increased to normal levels following 
removal of the native kidneys, splenectomy, and the provision of a well-functioning 
homograft. Anticomplement activity and elevated titers of C1 and C3 inactivators were 
observed in some patients, but these did not correlate with the changes in CH50. 
The findings confirm that the complement system participates in renal homograft 
rejection. 
From the Departments of Surgery and Pediatrics, University of Colorado School of Medicine 
and the Denver Veterans Administration Hospital, Denver, Colo. 
THE REI S accumulating evidence that se-
rum complement participates in the rejection 
of transplanted tissues and organs. 2, 4, 8, 9, 11 
In human recipients of renal homografts, 
Guiney and associates9 and Austen and Rus-
sell2 described a drop in CH50 and particu-
larly C2 levels coincident with rejection. 
Levine and associatesll have confirmed falls 
in whole complement with graft repudiation. 
Austen and RusselF and Carpenter and as-
sociates4 have demonstrated that decreases in 
either whole complement or its components 
may be delayed until sometime after clinically 
evident rejection. 
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In the present study, we have analyzed the 
whole complement and its components after 
human renal transplantation in order to clari-
fy further how various parts of the comple-
ment system are affected during convales-
cence, with and without rejection episodes. 
MATERIAL AND METHODS 
The case material. The ages of the 24 
patients ranged from 11 to 46 years, and 
were in terminal renal failure due to chronic 
glomerulonephritis (16 instances), chronic 
pyelonephritis (2), polycystic kidney disease 
(2), systemic lupus erythematosus (SLE) 
(2), familial medullary cystic disease ( 1) , 
and cystinosis (1). Immunosuppressive ther-
apy was provided by a triple-drug regimen 
consisting of azathioprine, prednisone, and 
antilymphocyte globulin (ALG) .18 
There were 27 transplantations in the 24 
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Fig. 1. Complement levels in three healthy volunteers studied at weekly intervals for six months. 
Only minor fluctuations occurred. 
recipients. Fifteen of the grafts were from re-
lated donors, and the other 12 were from 
cadavers. The patients were a complicated 
group in that six were receiving second 
homografts after having rejected their first 
ones. One recipient underwent both first and 
second transplants during the period of study. 
Another underwent a second and third trans-
plantation. A third recipient was given his 
third and fourth kidneys. In about two thirds 
of the cases, the natiYe patients' kidneys were 
removed in conjunction with splenectomy, 
and in the other third, the diseased kidneys 
were not disturbed. 
Serum complement assays. Blood samples 
were permitted to clot at room temperature 
for approximately one hour. Serum was 
separated by centrifugation at 3,000 rpm for 
15 minutes at 0 0 to 4° C. and stored at -700 
C. until used. All sera from an individual 
patient or control subject were analyzed 
simultaneously. 
Total complement activity was measured 
as hemolytic complement activity (CH50) 
according to Mayer12 and with the immune 
adherence hemagglutination (IA50) method 
of Nishioka.'4 The C1, C4, and C2 com-
ponents were assayed by stoichiometric tube 
titration with the use of EAC4hu, EACI gp, 
and EACI hu C4hu cells at a concentration of 
1.5 x 108 cells per milliliter, respectively. e, 13 
The C3 activity was assayed by immune ad-
herence15 with the use of EACpu 4hu 2hu cells. 
The anticomplement acti\ity (ACA) in 
the serum16, 17, eo and the presence of inac-
tivators to Cpo and C319 were assayed with 
previously described methods. 
Sera from the two patients with SLE were 
examined for complement-fixing antibody to 
DNA and heat-denatured DNA by micro-
technique.21 The LE test was performed with 
latex fixation.* 
Control studies. Complement (CH50 and 
IASO) was measured in 250 normal people; 
the e1, C4, C2 and C3 were analyzed in 100 
of them. In addition, three normal vol un-
*IIyland Laboratories. Los Angeles, Calif. 
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Fig, 2, Complement levels in 14 transplant recipi-
ents whose renal homo grafts displayed normal 
function throughout the time of postoperative 
study. The mean:': S.E. are given. The heavy line 
along the ordinate indicates the normal range. 
teers were studied weekly at the same time 
of day for six months, as it was demonstrated 
by Arata l that daily fluctuations within 8 
CHSO units might occur in an individual. 
The results are presented in Table I and 
Fig. l. 
Criteria of rejection, Rejection was defined 
by elevations in blood urea nitrogen and 
serum creatinine or by falls in creatinine 
clearance or urine sodium concentration. 
Three of these findings on two consecutive 
days were required to establish the diagnosis. 
RESULTS 
Renal recipients with normal homograft 
function, Fourteen patients including one 
with SLE always had good renal function 
after transplantation with no sign of rejec-
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Fig. 3. Complement levels during homograft re-
jection in seven patients. The CH50, IA50, C4, 
and C3 values all displayed marked decreases. The 
C 1 and C2 levels also fell but to a lesser degree. 
The mean:': S.E. are given. The heavy line along 
the ordinate indicates the normal range. 
tion. In this group, the pre- and postopera-
tive complement levels were essentially with-
in normal limits (Fig. 2), and in all but one 
patient, the fluctuations were no larger than 
in the normal volunteers. In the single ex-
ceptional case, transient moderate decreases 
in complement occurred two and six weeks 
after transplantation. 
Renal recipients with typical rejection 
episodes. Seven of the patients including one 
with SLE had initially well-functioning grafts 
that suffered from rejection episodes. Dur-
ing these times, there was always a significant 
decrease in CH50 and IASO titers (Fig. 3). 
The first four complement components 
showed different behavior patterns. The CI, 
G1, and C3 levels all dropped to subnormal 
values during the rejection episode with the 
most pronounced changes occurring for G4 
and C3. The C2 also decreased but did not 
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Fig. 4. The course in a patient who developed severe rejection six weeks after transplantation. 
Note marked drop in all the complement assays except the Cl. Following massive prednisone 
treatment encephalomyelitis developed, causing death 2 weeks later. 
Table I. Normal range of values for the 
various complement assays (mean ± 2 S.D.) 
reach values below the normal range (Fig. 
3) . 
Com- \ 
plement 
CH50 
IA50 
Cl 
C4 
C2 
C3 
Range 
25.3-49.7 
1,900- 5,500 
16,800- 22,800 
62,000-122,400 
700- 2,300 
2,500- 6,900 
Measurement 
U ni ts per mill iii ter 
Reciprocal of titer 
U ni ts per mill iii ter 
Units per milliliter 
U nits per milliliter 
U ni ts per millili ler 
Rejection episodes occurred in two patients 
at the same time as liver dysfunction, which 
was so severe that it ultimately caused death. 
Drops in the complement measures occurred 
to an extent not seen during rejection epi-
sodes without liver complications. Another 
patient developed severe rejection with 
marked complement changes six weeks after 
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transplantation (Fig. 4). Following massive 
prednisone treatment, death ensued from 
encephalomyelitis two weeks later. At au-
topsy, it was interesting that the swollen 
homograft had virtually no histopathologic 
findings of rejection. In the remaining four 
patients, recovery of homograft function was 
accompanied by the complement levels re-
turning to normal. 
Renal recipients with unusual rejection 
episodes. Three kidneys never functioned and 
probably underwent hyperacute rejection. 
Two of these grafts were transplanted con-
secutively to the same patient. Both recipients 
had preformed antibodies, although not 
against their donors. Two more transplants 
functioned well for a few hours but then 
shut down for 10 to 14 days before resuming 
significant urine excretion. A sixth graft be-
came anuric two weeks after transplantation 
and was removed; the organ was edematous 
and had tubular necrosis but with little cellu-
lar infiltration. 
After five of the foregoing six transplanta-
tions, there were definite and fluctuating de-
creases in CH50, IA50, C4, C3, and, to a 
lesser extent, C2 values. The Cl level re-
mained essentially unchanged, sometimes 
with small variations. In one of the patients 
who experienced a hyperacute rejection epi-
sode, the complement levels remained un-
changed. 
Two renal recipients with pre-existing 
SLE. The native kidneys and spleen were 
removed prior to renal transplantation. The 
lowest titers of CH50, IA50, C4, C3, and C2 
were recorded before the bilateral nephrec-
tomy. These titers slightly increased in the 
anephric state, and following successful trans-
plantation, they rose to normal levels. Anti-
bodies to DNA and heat-denatured DNA 
were detectable both before and after the 
bilateral nephrectomies. However, they dis-
appeared within a few days after transplan-
tation. At the same time, the LE test turned 
from slightly positive to negative. 
After operation, one of the recipients had 
neither rejection nor complement depression 
(Fig. 5). The other patient suffered a rejec-
tion episode during which the CH50, IA50, 
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Fig. 5. Complement levels in a patient whose orig-
inal disease was systemic lupus erythematosus. Very 
low complement values were slightly improved by 
bilateral nephrectomy and splenectomy. After suc-
cessful cadaveric renal transplantation was per-
formed, complement levels rose to normal. 
and C4 levels decreased significantly and re-
turned to normal concomitantly with reversal 
of the rejection; this course is included in 
Fig.4. 
Correlation between CH50 and anticom-
plement activity (ACA) and Cl and C3 in-
activators. Thirteen of the 24 patients be-
came Australia (Au) -antigen positive after 
transplantation, and in 11, an increased ACA 
was demonstrated. The data of ACA were 
plotted against CH50 titers in Fig. 6. There 
was no correlation, suggesting that the ACA 
had no measurable effect on the in vivo 
complement system in these cases. 
Cl and C3 inactivators were measured in 
six patients during normal renal homograft 
function and rejection. There was no correla-
tion between CH50 and Cl and C3 inactiva-
tors under either circumstance (Fig. 6). 
DISCUSSION 
Complement and its components in the 14 
homograft recipients who maintained good 
renal function remained continuously within 
normal range and were comparable to that 
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Fig. 6. Anticomplement activity (in 11 patients) and C1 and C3 inactivators (in six patients) 
related to the CH50 levels. No correlation was apparent. 
of the normal volunteers. This stability, which 
has been noted in renal recipients by Austen 
and Russell" and Gewurz and associates8 in-
dicates that immunosuppressive therapy as 
such has no influence on the complement 
system. 
In contrast, the development of postopera-
tive rejection was invariably reflected by 
changes within the complement system. These 
occurred simultaneously with the development 
of the rejection rather than afterward, as has 
been reported by others.2, 4 There were de-
pressions of CH50, IA50, C4, C3, and, to a 
lesser degree, Cl and C2. With reversal of re-
jection, the CH50 and the decreased compo-
nents returned to nonnallevels. 
It was previously reported by Austen and 
Russell2 that the C2 titers fell to half their 
preoperative values during rejection, Ge-
wurz and co-workers,s Carpenter and associ-
ates,4 and Levine and colleaguesll demon-
strated a similar decrease of C2 f3lC globu-
lin and whole complement, respectively. None 
of these authors stressed the most impressive 
decrease of serum C4 complement compo-
nent, although Carpenter and associates5 de-
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scribed a moderate hypercatabolism of radio-
active C4 and C3 intravenously injected into 
renal allograft recipients undergoing rejec-
tion. 
In addition to those instances in which the 
diagnosis of classical rejection was unequiv-
ocal, there were six cases of transient or 
permanent homograft failure in which the 
role of immunologic mechanisms was less 
clear as the result of the features of the clin-
ical course. In five of the latter recipients, 
there were decreased levels of CH50, IA50, 
C4, and C3 during the period of graft non-
function. In addition to an accelerated cell-
mediated immunologic reaction, other possi-
bilities for the complement depletion could 
be either by deposition in the glomeruli of 
antibodies to glomerular basement membrane 
or by deposition of circulating antigen-anti-
body complexes. Both of the latter reactions 
are complement-consuming.6• 7 
The two patients with SLE were of special 
interest because the disease that destroyed 
their native kidneys was accompanied by 
complement changes similar to those of re-
jection. When first evaluated, both potential 
recipients had extremely low levels of CH50, 
IA50, C4, C2, and C3. Following bilateral 
nephrectomy, there was a slight elevation of 
complement but by no means to normal level. 
After provision of well-functioning renal 
homografts, the complement returned to nor-
mal level, at which it remained in one in-
stance and became secondarily and transi-
ently depressed in the other with the onset 
of rejection. The explanation for complement 
restoration by virtue of the homotransplanta-
tion is unclear. 
An additional group of interesting patients 
was made up of the 13 who developed evi-
dence of Australia antigenemia after trans-
plantation. In 11 of these recipients, increases 
of anticomplementary activity (ACA) was 
found. In spite of the significant titers of 
ACA, these had no correlation with CH50. 
In addition, the C1 and C3 inactivators 
which were measured in six patients during 
normal graft function and rejection did not 
have any correlation with the complement 
levels. 
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